News > Remdesivir made affordable for India; costs ₹4,700 per vial
Remdesivir made affordable for India; costs ₹4,700 per vial
International Business Times | 05/08/2020 08:45 AM | Click to read full article
Jubilant Life Sciences Ltd on Monday announced the launch of Remdesivir for injection, under the brand name 'JUBI-R', at a price of Rs 4,700 per vial of 100 mg.
Remdesivir is an antiviral drug that has received Emergency Use Authorisation by the US FDA for treatment of Covid-19 in adults and children hospitalized with severe disease. The company said it will make the drug available to over 1,000 hospitals providing COVID treatment in India through its distribution network.